STACY GLASS: Open Payments
NPI 1487277513 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,278 in 113 payments from 33 companies in 2025. Trend: 2023 $1,048 · 2024 $2,308 · 2025 $2,278
Food & beverage: $2,278
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $277 |
| Janssen Biotech, Inc. | 12 | $236 |
| Regeneron Healthcare Solutions, Inc. | 8 | $155 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $127 |
| Merck Sharp & Dohme LLC | 6 | $123 |
| Genentech USA, Inc. | 6 | $111 |
| Exelixis Inc. | 4 | $106 |
| AstraZeneca Pharmaceuticals LP | 6 | $105 |
| Incyte Corporation | 4 | $86 |
Products named: LIBTAYO, Nubeqa, CABOMETYX, REBLOZYL, TALVEY, ERLEADA, EPKINLY, FRUZAQLA.
Industry payments across AL — which companies pay providers there.
